Skip to main content

AusPAR: Abrysvo

Australian Public Assessment Report
Device/Product Name
Abrysvo
Active ingredients
Recombinant respiratory syncytial virus pre-fusion F protein
AusPAR Date
Published
Submission Number
2023-01210-1-2
Submission Type
New biological entity
Decision
Approved

Help us improve the Therapeutic Goods Administration site